ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Merck KGAA (PK)

Merck KGAA (PK) (MKGAF)

145.43
-2.82
(-1.90%)
Closed January 08 3:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
145.43
Bid
143.46
Ask
150.46
Volume
82
145.43 Day's Range 146.55
140.005 52 Week Range 200.56
Market Cap
Previous Close
148.25
Open
146.55
Last Trade
16
@
145.43
Last Trade Time
Financial Volume
US$ 11,986
VWAP
146.1666
Average Volume (3m)
716
Shares Outstanding
129,242,251
Dividend Yield
1.47%
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
20.99B
Net Profit
2.82B

About Merck KGAA (PK)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Website
Headquarters
Darmstadt, Deu
Founded
1987
Merck KGAA (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker MKGAF. The last closing price for Merck KGAA (PK) was US$148.25. Over the last year, Merck KGAA (PK) shares have traded in a share price range of US$ 140.005 to US$ 200.56.

Merck KGAA (PK) currently has 129,242,251 shares outstanding. The market capitalization of Merck KGAA (PK) is US$19.16 billion.

MKGAF Latest News

Data on Merck KGaA's L-BLP25 - Analyst Blog

Merck KGaA (MKGAF )  recently presented detailed results on its oncology candidate L-BLP25, from the phase III study, START (Stimulating Targeted Antigenic Responses To NSCLC). Results...

Merck KGaA Posts Higher Y/Y Earnings - Analyst Blog

Merck KGaA (MKGAF) reported first quarter 2013 earnings per American Depositary Receipt (ADR) of $2.79, up 28.1% year over year. Revenues for the reported quarter were up 4.4% year over year...

Merck KGaA-CBRX Renew Agreement - Analyst Blog

Merck KGaA (MKGAF) and Columbia Laboratories, Inc. (CBRX) recently renewed a license and supply agreement for Crinone (progesterone gel), extending it for an additional five years. This...

Sanofi Reports Lemtrada Data - Analyst Blog

Sanofi’s (SNY) subsidiary, Genzyme, recently announced interim data on its multiple sclerosis (MS) candidate, Lemtrada (alemtuzumab), from the first year of an extension study. ...

Merck KGaA-BMY Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a deal with Bristol-Myers Squibb (BMY) for the promotion of different formulations of Glucophage (metformin hydrochloride) in China. Glucophage is used for...

Merck KGaA - Nordic Bioscience Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a strategic deal with Nordic Bioscience Clinical Development A/S for its pipeline candidate, sprifermin (recombinant human FGF-18). Sprifermin is being...

Threshold Cuts Loss, Misses Sales - Analyst Blog

Threshold Pharmaceuticals Inc. (THLD) reported fourth-quarter 2012 net loss per share of 10 cents, narrower than the Zacks Consensus Estimate of a loss of 12 cents and the year-ago loss of 11...

Strong Quarter for Merck KGaA - Analyst Blog

Merck KGaA (MKGAF) reported fourth quarter 2012 earnings per American Depository Receipt (ADR) of $2.66, up 18.8% year over year. Revenues for the reported quarter were up 8% year over year...

Positive Data from BMRN's PKU-016 - Analyst Blog

BioMarin Pharmaceutical Inc. (BMRN) recently announced positive results from the PKU-016 ASCEND study. This is the largest randomized controlled study evaluating the safety and therapeutic...

Threshold/Merck KGaA Drug in Study - Analyst Blog

Threshold Pharmaceuticals, Inc. (THLD) and Merck KGaA (MKGAF) recently announced the commencement of a global phase III study (MAESTRO) on their hypoxia-targeted candidate, TH-302. The study...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.81-1.22928552024147.24154.065144.1981681149.03284843CS
4-4.714-3.13965260017150.144154.065140.0051229146.25562056CS
12-24.224-14.2784726561169.654183.171140.005716147.90729835CS
26-20.27-12.2329511165165.7200.56140.005427155.05891073CS
52-7.87-5.13372472277153.3200.56140.005598161.93383927CS
156-84.57-36.7695652174230238.985140.005646171.12419394CS
26019.8315.7882165605125.6264.482617157.90213046CS

MKGAF - Frequently Asked Questions (FAQ)

What is the current Merck KGAA (PK) share price?
The current share price of Merck KGAA (PK) is US$ 145.43
How many Merck KGAA (PK) shares are in issue?
Merck KGAA (PK) has 129,242,251 shares in issue
What is the market cap of Merck KGAA (PK)?
The market capitalisation of Merck KGAA (PK) is USD 19.16B
What is the 1 year trading range for Merck KGAA (PK) share price?
Merck KGAA (PK) has traded in the range of US$ 140.005 to US$ 200.56 during the past year
What is the reporting currency for Merck KGAA (PK)?
Merck KGAA (PK) reports financial results in EUR
What is the latest annual turnover for Merck KGAA (PK)?
The latest annual turnover of Merck KGAA (PK) is EUR 20.99B
What is the latest annual profit for Merck KGAA (PK)?
The latest annual profit of Merck KGAA (PK) is EUR 2.82B
What is the registered address of Merck KGAA (PK)?
The registered address for Merck KGAA (PK) is FRANKFURTER STRASSE 250, DARMSTADT, 64293
What is the Merck KGAA (PK) website address?
The website address for Merck KGAA (PK) is www.merck.de
Which industry sector does Merck KGAA (PK) operate in?
Merck KGAA (PK) operates in the PHARMACEUTICAL DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SIRCSolar Integrated Roofing Corporation (PK)
US$ 0.0002
(19,900.00%)
50.24M
INTKIndustrial Nanotech Inc (PK)
US$ 0.0001
(9,900.00%)
3.42M
GEGIGenesis Electronics Group Inc (CE)
US$ 0.0001
(9,900.00%)
3.55M
FBCDFBC Holding Inc (PK)
US$ 0.0001
(9,900.00%)
5M
TTCFQTattooed Chef Inc (CE)
US$ 0.0001
(9,900.00%)
39.88k
PSRUValiant Eagle Inc (PK)
US$ 0.000001
(-99.00%)
15.67M
CGSICGS International Inc (CE)
US$ 0.000001
(-99.00%)
413
RNVARennova Health Inc (CE)
US$ 0.000001
(-99.00%)
4M
GTGPGlobal Technologies Group Inc (CE)
US$ 0.000001
(-99.00%)
9k
GDPEFResource Capital Gold Corporation (CE)
US$ 0.000001
(-99.00%)
400
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0038
(-5.00%)
255.42M
HMBLHUMBL Inc (PK)
US$ 0.0009
(5.88%)
227.48M
PSYCPSYC Corporation (PK)
US$ 0.0003
(50.00%)
148.5M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(0.00%)
118.14M
GTLLGlobal Technologies Ltd (PK)
US$ 0.0003
(50.00%)
110.77M

Discussion

View Full Feed
EmpressMonk25 EmpressMonk25 3 minutes ago
Hahaaha...nailed it!
HMBL
splintered sunlight splintered sunlight 3 minutes ago
LMFAO

SMH

The 'SuperApp" was supposed to be released.

What's negative? It was supposed to be rolled out months ago. It wasn't. And what was the company's explanation?

There is a reason why a lot of people are losing a lot of money if the
BBUZ
krab krab 4 minutes ago
Thursday, Jan 9th the US Markets are closed for national day of mourning for Jimmy Carter.
President Carter was 100 times better than crooked Brandon we had for 4 years !!
FNMA
trunkmonk trunkmonk 4 minutes ago
She finally figured out she ain’t gonna get high risk loans for low credit entitled housing recipients at the expense the global economy and taxpaying shareholders? Obama never told her there would be days like this?
FNMA
jimr1717 jimr1717 5 minutes ago
.60, .50,.40, .20Zzzzzzz
ELTP
chipboarder chipboarder 5 minutes ago
“Medical Monitoring and Testing Devices” listed with a green check sounds like a direct hit!
LQMT
Hoskuld Hoskuld 7 minutes ago
When is FDA final AD guidance supposed to come? Or is there EVER a final guidance?

"This draft guidance revises the previous draft guidance for industry of the same name issued on February 16, 2018."
AVXL
boi568 boi568 7 minutes ago
The cross compatibility issue may be mitigated by the fact that there is a wealth of data on the ADL deterioration rate over time. I would think Anavex may be able to find a pretty close population match if they try.
AVXL
gitreal gitreal 8 minutes ago
To her credit, Kate has done more "DD" than most AABB investors but unfortunately the quality of her DD is abysmal. Picking a random pasture miles from the rockpile on the hill or the "plant" and applying some kind of significance to it....is just plain weird. The cow references are about as tire
AABB
Bigfootbud Bigfootbud 9 minutes ago
$HRAL um why buy volume? 🤍 https://investorshub.advfn.com/uimage/uploads/2025/1/8/affqeHRAL_WHY.jpg
HRAL
boi568 boi568 10 minutes ago
I'm not as surprised about the improvement in the ADL result. I have been expecting very good news on that front from the OLE ever since I started thinking that 48 weeks was too brief a period to get a proper read on that measurement -- but three years later was plenty of time.
AVXL
Don316 Don316 11 minutes ago
Hey everyone. I’m still holding the same shares that I held when the SP was almost $.04. I’ve been blessed with the opportunity here to add more. DBMM shareholders, STAY FOCUSED! Tune out the drivel. What an exciting time to be a shareholder!!
DBMM
CorsairNavigator20 CorsairNavigator20 11 minutes ago
At least they know what the product is supposed to be and how it works
MRKR
nbm16yankees nbm16yankees 12 minutes ago
here's the contents of tonight's news release.


Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting
January 08 2025 - 6:12PM

Senseonics Holdings, Inc. (NYSE American
SENS
ChiJ ChiJ 12 minutes ago
I have been invested for 5 years and cannot imagine hanging in there for 15. I feel like I have either seen it all or heard about all of it here. I stick around because i believe this stock is going to rocket in the next 2 years.
KBLB
Bigfootbud Bigfootbud 13 minutes ago
umm... why am I seeing posts only from 2 days ago? $HIRU
HIRU
nbm16yankees nbm16yankees 14 minutes ago
no reverse split. Special meeting cancelled. News out tonight concerning that plus guidance

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting • GlobeNewswire Inc. • 01/08/2025 11:12:09 PM
SENS
StocksGoneWild StocksGoneWild 14 minutes ago
His last tweet a few days ago had 1000 likes. How many likes do your tweets get? Reggie Jackson is literally a super celebrity. Everyone knows who he is. To try to diminish him like this is pathetic and disgusting. He's a brilliant man, and he knows way more about business than guess who?
MONI
WALLnut WALLnut 14 minutes ago
Tomorrow will be the first time in Stock Market History we had a one day close for three weeks in a row.



RDGL
RDGL
Hosai Hosai 17 minutes ago
From what I understand the delayed start type analysis is the most robust type of analysis one can glean from an OLE as it in a sense is still comparing the dosed with placebo - just 2-3 years later down the line. Obv the placebo controlled trial is the most important part to regulartors so having f
AVXL
Demolition Man Demolition Man 20 minutes ago
Thanks a bunch Matteo2017!! Do you or anyone think $AABB could possibly buy $KYNC out?
If so what would a reasonable buyout offer price be for us? I’d be happy with .01 a share.
AABB KYNC
Hosai Hosai 20 minutes ago
I agree, it's very surprising they were able to go from no significance at all in terms of p value for ADL (though effect line slightly trended in right direction) to ADL being significant at 192 weeks with p value 0.02 when you consider the 'n' had to be have been a lot lower by week 192 and its ha
AVXL
Steady_T Steady_T 20 minutes ago
A fairly large trading range.
AVXL

Your Recent History

Delayed Upgrade Clock